State Laws Can Promote Hepatitis C Virus Screening

Share this content:
State Laws Can Promote Hepatitis C Virus Screening
State Laws Can Promote Hepatitis C Virus Screening

MONDAY, Oct. 2, 2017 (HealthDay News) -- Mandating health care providers to offer hepatitis C virus (HCV) screening can increase screening rates and linkage to care among those with newly diagnosed infection, according to research published in the Sept. 29 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Noting that in 2014 New York enacted a law requiring health care providers to offer HCV antibody screening to those born from 1945 to 1965, Colleen A. Flanigan, R.N., from the New York State Department of Health in Albany, and colleagues used survey data from clinical laboratories and Medicaid claims and encounter data, as well as HCV surveillance data, to examine the number of individuals tested for HCV and linkage with care among those with newly diagnosed HCV infection.

The researchers observed a 51 percent increase in specimens submitted for HCV testing during the first year of the HCV law implementation; among active Medicaid clients, testing rates increased 52 percent. There was an increase in linkage to care among persons with newly diagnosed HCV infection, by approximately 40 percent in the state of New York and 11 percent in New York City.

"These findings highlight the potential for state laws to promote HCV testing and the utility of HCV surveillance and Medicaid claims data to monitor the quality of HCV testing and linkage to care for HCV-infected persons," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016

CDC: Birth Rate for 10- to-14-Year-Olds at Record ...

Reduction in birth rates for all race and Hispanic origin groups; largest decline in non-Hispanic blacks

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lower mortality seen with lonafarnib monotherapy after 2.2 years compared with no treatment

About 40 Percent of Men Report Experiencing Weight Stigma

About 40 Percent of Men Report Experiencing Weight ...

Experience of weight stigma associated with increased odds of underweight or obesity

is free, fast, and customized just for you!

Already a member?

Sign In Now »